just a reminder the last 2 PRs' issued out of mgmt were 8k'd .. breaking with prior patterns .. for reasons only mgmt currently knows ..

April 16, 2018
INNOVATION PHARMACEUTICALS DATA FROM PHASE 2 BRILACIDIN ORAL MUCOSITIS (OM) TRIAL IN HEAD AND NECK CANCER SHOW NOTABLE REDUCTIONS IN MEDIAN DURATION OF SEVERE OM AND IN NUMBER OF UNPLANNED VISITS...

April 9, 2018
INNOVATION PHARMACEUTICALS PHASE 2 ORAL MUCOSITIS TRIAL ADDITIONAL DATA SHOW BRILACIDIN-OM DEMONSTRATED A SIGNIFICANT REDUCTION IN THE INCIDENCE OF SEVERE ORAL MUCOSITIS...


http://www.ipharminc.com/press-release/

http://www.ipharminc.com/financials/

 
 
 
Date	        Open	High	Low	Close*	Adj Close**	Volume 
 
Apr 18, 2018	0.4900	0.5000	0.4600	0.4700	0.4700	270,700 
 
Apr 17, 2018	0.5300	0.5300	0.4800	0.4900	0.4900	265,900 
 
Apr 16, 2018	0.5100	0.5100	0.4800	0.5000	0.5000	296,000 
 
Apr 13, 2018	0.5000	0.5300	0.4900	0.5100	0.5100	181,000 
 
Apr 12, 2018	0.5500	0.5500	0.5000	0.5100	0.5100	198,200 
 
Apr 11, 2018	0.5900	0.5900	0.5200	0.5300	0.5300	172,300 
 
Apr 10, 2018	0.6000	0.6300	0.5700	0.5700	0.5700	116,100 
 
Apr 09, 2018	0.6100	0.6300	0.5500	0.5800	0.5800	391,300 
 
 

https://finance.yahoo.com/quote/IPIX/history?p=IPIX

4kids